CORBUS PHARMACEUTICALS HLDGS's ticker is CRBP and the CUSIP is 21833P103. A total of 111 filers reported holding CORBUS PHARMACEUTICALS HLDGS in Q1 2021. The put-call ratio across all filers is 0.92 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2021 | $7,000 | -93.8% | 10,596 | -82.9% | 0.00% | – |
| Q2 2021 | $113,000 | +109.3% | 61,837 | +126.8% | 0.00% | – |
| Q1 2021 | $54,000 | +54.3% | 27,262 | -1.9% | 0.00% | – |
| Q4 2020 | $35,000 | -75.4% | 27,791 | -64.7% | 0.00% | – |
| Q3 2020 | $142,000 | -84.4% | 78,719 | -27.3% | 0.00% | -100.0% |
| Q2 2020 | $909,000 | +178.0% | 108,299 | +73.8% | 0.00% | – |
| Q1 2020 | $327,000 | +138.7% | 62,310 | +147.8% | 0.00% | – |
| Q4 2019 | $137,000 | +77.9% | 25,148 | +59.8% | 0.00% | – |
| Q3 2019 | $77,000 | -37.4% | 15,736 | -11.4% | 0.00% | – |
| Q2 2019 | $123,000 | – | 17,759 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Knoll Capital Management, LLC | 5,045,870 | $3,107,000 | 1.71% |
| ETF MANAGERS GROUP, LLC | 14,138,998 | $8,534,000 | 0.17% |
| Ikarian Capital, LLC | 948,526 | $584,000 | 0.09% |
| IQ EQ FUND MANAGEMENT (IRELAND) Ltd | 318,668 | $196,000 | 0.03% |
| Platform Technology Partners | 45,000 | $28,000 | 0.01% |
| XTX Topco Ltd | 34,476 | $21,000 | 0.01% |
| PINNACLE ASSOCIATES LTD | 947,083 | $583,000 | 0.01% |
| Penserra Capital Management LLC | 537,236 | $330,000 | 0.01% |
| Mirae Asset Global Investments Co., Ltd. | 4,070,006 | $2,506,000 | 0.01% |
| Tekla Capital Management LLC | 154,310 | $95,000 | 0.00% |